Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBács-Kiskun County Teaching Hospital

About this trial

Magnetically controlled capsule endoscopy (MCCE) is an outstanding opportunity for the painless endoscopic screening of the esophagus and stomach before small bowel examiantion. Further improvement in patients positioning might increase the esophageal transit time of the capsule endoscope and could improve the sensitivity and specificity of the esophageal MCCE investigation. Our present study aimed to compare the visualization of the esophagus (especially the Z-line) with different capsule swallowing protocols.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

known or suspected stricture in the GI tract

previous surgery with bowel anastomosis

swallowing complaints

dementia

Trial population

Every patient who met the eligibility criteria and had MCCE examination with esophageal protocol.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 1 trial group
Group A: Capsule endoscopy patients

Trial outcomes

Primary outcomes

1

Reflux esophagitis

Proportion and the severity of reflux (Los Angeles classification) comparing to gastroscopy

Time frame
1 year
2

Diseases

Proportion of other disorders of oesophagus and stomach comparing to gastroscopy

Time frame
1 year
3

Stomach examination

Analyze the visualisation of gastric mucosa with MACE system

Time frame
1 year

Secondary outcomes

1

Restrain time

Analysing the correlation with MCCE system between esophageal transit time and diagnostic yield.

Time frame
1 year
2

Cleanliness

Analysis of stomach preparation with a special software concerning the percentage of clean and covered areas.

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.